Review



ril 17a  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems ril 17a
    Ril 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/Recombinant+Mouse+IL-17A+(CHO-expressed)+Protein/pmc11430450-232-4-9
    Average 94 stars, based on 15 article reviews
    ril 17a - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Infection:

    Article Title: The Protective Role of Interleukin 17A in Acinetobacter baumannii Pneumonia Is Associated with Candida albicans in the Airway.
    Article Snippet: .. Rats inoculated with C. albicans prior to A. baumannii infection were divided into two groups: those treated with rIL-17A (catalog no. 8410-IL; R&D Systems, Minneapolis, MN, USA) (AWC1IL-17A group, n = 17) and those receiving no treatment (AWC group; n = 15). ..

    Article Title: Pregnancy enhances antiviral immunity independent of type I IFN but dependent on IL-17–producing γδ + T cells in the nasal mucosa
    Article Snippet: .. Nonpregnant mice were administered rIL-17A (1 μg per mouse; R&D Systems, #7956-ML-025/CF) intranasally in 10 μl of PBS (5 μl per naris) 2 hours before IAV infection (50 PFU intranasally). ..

    Recombinant:

    Article Title: Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis
    Article Snippet: .. Intraperitoneally, 10 μg/0.01 ml/animal of recombinant mouse cytokine(s) was administered in the study groups of mice: rIL-17A ([Group III; M3] [R & D System, Cat. No. 421-ML-025]), rIFN-γ ([Group IV; M4] [R & D System, Cat. No. 485-MI-100]), and both rIL-17A as well as rIFN-γ (Group V; M5). ..

    Western Blot:

    Article Title: Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Article Snippet: .. Primary antibodies used in this study include: rabbit anti-IL-17RA 96 (for western blot, Cell signaling, cat#12661), Mouse anti-α-SMA (Sigma, cat#A5228-100ul), mouse anti-97 GAPDH (Millipore, cat#CBL251), goat anti-collagen type I (Millipore, cat#AB758), mouse anti-fibronectin 98 (BD Transduction Laboratories, cat#610078), rabbit anti-Phospho-STAT3 (Cell signaling, cat#9145), 99 rabbit-anti-STAT3 (Cell signaling, cat#4904), rabbit anti-NF-кB P65 (Cell signaling, cat#8242), rabbit anti-100 Phospho-NF-кBP65 (cell signaling, cat#3033), mouse anti-IL-17RA (49M4D2) (for immunostaining, Novus 101 Biologicals, cat#NBP2-25258), mouse anti-human fibroblasts (TE-7) (Millipore, cat#CBL271), Rabbit anti-102 FSP-1 (Millipore, cat#07-2274), goat anti-rabbit Alexa Fluor 488-conjugated antibody (Invitrogen, cat# 103 A11008), HRP conjugated goat anti-mouse or anti-rabbit antibody (Cell Signaling), AZD1480 104 (Selleckchem, cat#S2162). rIL-17A was purchased from R&D systems (cat317-ILB-050), and 105 pharmaceutical inhibitor QNZ (EVP4593) was purchased from Selleckchem (cat#S4902), tofacitinib was 106 supplied by Pfizer. ..

    Immunostaining:

    Article Title: Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Article Snippet: .. Primary antibodies used in this study include: rabbit anti-IL-17RA 96 (for western blot, Cell signaling, cat#12661), Mouse anti-α-SMA (Sigma, cat#A5228-100ul), mouse anti-97 GAPDH (Millipore, cat#CBL251), goat anti-collagen type I (Millipore, cat#AB758), mouse anti-fibronectin 98 (BD Transduction Laboratories, cat#610078), rabbit anti-Phospho-STAT3 (Cell signaling, cat#9145), 99 rabbit-anti-STAT3 (Cell signaling, cat#4904), rabbit anti-NF-кB P65 (Cell signaling, cat#8242), rabbit anti-100 Phospho-NF-кBP65 (cell signaling, cat#3033), mouse anti-IL-17RA (49M4D2) (for immunostaining, Novus 101 Biologicals, cat#NBP2-25258), mouse anti-human fibroblasts (TE-7) (Millipore, cat#CBL271), Rabbit anti-102 FSP-1 (Millipore, cat#07-2274), goat anti-rabbit Alexa Fluor 488-conjugated antibody (Invitrogen, cat# 103 A11008), HRP conjugated goat anti-mouse or anti-rabbit antibody (Cell Signaling), AZD1480 104 (Selleckchem, cat#S2162). rIL-17A was purchased from R&D systems (cat317-ILB-050), and 105 pharmaceutical inhibitor QNZ (EVP4593) was purchased from Selleckchem (cat#S4902), tofacitinib was 106 supplied by Pfizer. ..



    Similar Products

    95
    MedChemExpress recombinant il 17a ril 17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Recombinant Il 17a Ril 17a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/IL17A+Antibody/pmc13085363-39-44-50
    Average 95 stars, based on 1 article reviews
    recombinant il 17a ril 17a - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Thermo Fisher carrier-free mouse ril-17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Carrier Free Mouse Ril 17a, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/anti+il+4/pm40632810-433-23-28
    Average 90 stars, based on 1 article reviews
    carrier-free mouse ril-17a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse ril-17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Mouse Ril 17a, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/anti+il+4/pmc12258563-358-18-23
    Average 90 stars, based on 1 article reviews
    mouse ril-17a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    R&D Systems ril 17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Ril 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/Recombinant+Mouse+IL-17A+(CHO-expressed)+Protein/pmc11430450-232-4-9
    Average 94 stars, based on 1 article reviews
    ril 17a - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    Novoprotein ril-17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Ril 17a, supplied by Novoprotein, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/ril+17a/pm39298642-59-9-36
    Average 90 stars, based on 1 article reviews
    ril-17a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    PeproTech ril-17a
    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection <t>increases</t> <t>IL-17A</t> content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway
    Ril 17a, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/ril+17a/pm39298642-59-9-22
    Average 90 stars, based on 1 article reviews
    ril-17a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    R&D Systems ril-17a protein
    A Experimental scheme of C. rodentium infection model ( Methods ). B Representative periodic acid–Schiff (PAS) staining images of colons of Rorc-cre – Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 7 post the infection as in ( A ). C Quantification of the histological scores of images as in ( B ) ( n = 5 mice per group). D, E Representative images of bacterial load determined by bioluminescent imaging in the colon ( D ) and the quantification ( E ) ( n = 6 mice per group). F-I Representative flow plots showing the intracellular abundance of IL-22 ( F ) or <t>IL-17A</t> ( H ) in total, CCR6 + and CCR6 – ILC3s from siLPs. Quantification of the frequencies of IL-22 ( G, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) or IL-17A ( I, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) -expressing cells in each compartment. Data are representative of two ( B-E, F, H ) or are pooled from two ( G, I ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, E, G, I ).
    Ril 17a Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/ril+17/pmc11252441-280-10-12
    Average 90 stars, based on 1 article reviews
    ril-17a protein - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    PeproTech ril-17a 210-17
    A Experimental scheme of C. rodentium infection model ( Methods ). B Representative periodic acid–Schiff (PAS) staining images of colons of Rorc-cre – Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 7 post the infection as in ( A ). C Quantification of the histological scores of images as in ( B ) ( n = 5 mice per group). D, E Representative images of bacterial load determined by bioluminescent imaging in the colon ( D ) and the quantification ( E ) ( n = 6 mice per group). F-I Representative flow plots showing the intracellular abundance of IL-22 ( F ) or <t>IL-17A</t> ( H ) in total, CCR6 + and CCR6 – ILC3s from siLPs. Quantification of the frequencies of IL-22 ( G, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) or IL-17A ( I, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) -expressing cells in each compartment. Data are representative of two ( B-E, F, H ) or are pooled from two ( G, I ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, E, G, I ).
    Ril 17a 210 17, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ril+17a/ril+17a/pm38639570-176-14-16
    Average 90 stars, based on 1 article reviews
    ril-17a 210-17 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection increases IL-17A content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway

    Journal: Journal of Animal Science and Biotechnology

    Article Title: Baicalin alleviates mastitis in dairy cows by targeting IL-17RA to inhibit IL-17 signaling pathway activation

    doi: 10.1186/s40104-026-01401-2

    Figure Lengend Snippet: Schematic overview of baicalin's mechanism in alleviating mastitis by regulating the IL-17RA-mediated IL-17 signaling pathway. A Oral administration of baicalin to mice and dairy cows. B In vivo release of LPS by E. coli . C LPS activated the TLR4/MyD88/NF-κB pathway in epithelial cells. D NF-κB was activated within the cell nucleus. E E. coli infection increases IL-17A content in mammary glands. F IL-17A binds to IL-17RA on the cell membrane surface, thereby activating the IL-17 signaling pathway. G Activation of the MAPK signaling pathway and ERK signaling pathway. H Production of IL-6, TNFα and IL-1β. I TNFα activated TNF signaling pathway. J TJ structure damage. K Baicalin inhibits IL-17RA signal transduction, thereby preventing activation of the IL-17 signaling pathway

    Article Snippet: An in vitro mastitis model was established by treating cells with 5 μg/mL LPS (Sigma, USA) for 12 h. Baicalin (purity ≥ 95%) was purchased from Macklin (Shanghai, China), with a concentration of 20 μmol/L for 24 h. Furthermore, the TNFα inhibitor SPD304 and recombinant IL-17A (rIL-17A) were purchased from MedChemExpress (MCE, USA) and were used at concentrations of 5 μmol/L (for 2 h) and 100 ng/mL (for 12 h), respectively.

    Techniques: In Vivo, Infection, Membrane, Activation Assay, Transduction

    A Experimental scheme of C. rodentium infection model ( Methods ). B Representative periodic acid–Schiff (PAS) staining images of colons of Rorc-cre – Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 7 post the infection as in ( A ). C Quantification of the histological scores of images as in ( B ) ( n = 5 mice per group). D, E Representative images of bacterial load determined by bioluminescent imaging in the colon ( D ) and the quantification ( E ) ( n = 6 mice per group). F-I Representative flow plots showing the intracellular abundance of IL-22 ( F ) or IL-17A ( H ) in total, CCR6 + and CCR6 – ILC3s from siLPs. Quantification of the frequencies of IL-22 ( G, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) or IL-17A ( I, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) -expressing cells in each compartment. Data are representative of two ( B-E, F, H ) or are pooled from two ( G, I ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, E, G, I ).

    Journal: Nature Communications

    Article Title: Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity

    doi: 10.1038/s41467-024-50266-4

    Figure Lengend Snippet: A Experimental scheme of C. rodentium infection model ( Methods ). B Representative periodic acid–Schiff (PAS) staining images of colons of Rorc-cre – Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 7 post the infection as in ( A ). C Quantification of the histological scores of images as in ( B ) ( n = 5 mice per group). D, E Representative images of bacterial load determined by bioluminescent imaging in the colon ( D ) and the quantification ( E ) ( n = 6 mice per group). F-I Representative flow plots showing the intracellular abundance of IL-22 ( F ) or IL-17A ( H ) in total, CCR6 + and CCR6 – ILC3s from siLPs. Quantification of the frequencies of IL-22 ( G, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) or IL-17A ( I, Rorc-cre – Fcer1g f/f , n = 11 mice; Rorc-cre + Fcer1g f/f , n = 8 mice) -expressing cells in each compartment. Data are representative of two ( B-E, F, H ) or are pooled from two ( G, I ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, E, G, I ).

    Article Snippet: Mice were injected intraperitoneally with a dose of 1 μg rIL-17A protein (R&D Systems) or 0.8 μg rIL-22 protein (R&D Systems) 6 h before C. albicans infection, followed by a booster dose of the same cytokine at 24 h after infection.

    Techniques: Infection, Staining, Imaging, Expressing, Two Tailed Test

    A Heatmap showing the expression (color bar, Z score) of genes (rows) significantly induced in ILC3s by the fungal infection (Supplementary Fig. ) across different genotypes and conditions (columns) ( Rorc-cre – Fcer1g f/f PBS, n = 4 mice; Rorc-cre + Fcer1g f/f C.A ., n = 4 mice; Rorc-cre – Fcer1g f/f C.A ., n = 3 mice). C.A . represents Candida albicans . B Quantification of the overall expression ( Methods ) of the genes in ( A ). C Quantification of total, CCR6 + and CCR6 – ILC3s in the siLPs of Rorc-cre − Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 5 post the infection ( n = 6 mice per group). D-G Representative flow plots showing the intracellular abundance of IL-22 ( D ) or IL-17A ( F ) in total, CCR6 + and CCR6 – ILC3s on day 5 post the infection. Quantification of the frequencies of IL-22 ( E, Rorc-cre – Fcer1g f/f , n = 7 mice; Rorc-cre + Fcer1g f/f , n = 6 mice) or IL-17A ( G, Rorc-cre – Fcer1g f/f , n = 7 mice; Rorc-cre + Fcer1g f/f , n = 6 mice) -expressing cells in each compartment. H, I Representative flow plots showing the phosphorylation of JAK1, JAK2 and JAK3 in total ILC3s from siLPs of indicated mice on day 5 post the C. albicans infection ( H ). Quantification of MFI ( I, Rorc-cre – Fcer1g f/f , n = 5 mice; Rorc-cre + Fcer1g f/f , n = 4 mice). Data are representative of two ( C – G ) or one ( H , I ) or from two ( A , B ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( B, C, E, G, I ).

    Journal: Nature Communications

    Article Title: Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity

    doi: 10.1038/s41467-024-50266-4

    Figure Lengend Snippet: A Heatmap showing the expression (color bar, Z score) of genes (rows) significantly induced in ILC3s by the fungal infection (Supplementary Fig. ) across different genotypes and conditions (columns) ( Rorc-cre – Fcer1g f/f PBS, n = 4 mice; Rorc-cre + Fcer1g f/f C.A ., n = 4 mice; Rorc-cre – Fcer1g f/f C.A ., n = 3 mice). C.A . represents Candida albicans . B Quantification of the overall expression ( Methods ) of the genes in ( A ). C Quantification of total, CCR6 + and CCR6 – ILC3s in the siLPs of Rorc-cre − Fcer1g f/f and Rorc-cre + Fcer1g f/f mice on day 5 post the infection ( n = 6 mice per group). D-G Representative flow plots showing the intracellular abundance of IL-22 ( D ) or IL-17A ( F ) in total, CCR6 + and CCR6 – ILC3s on day 5 post the infection. Quantification of the frequencies of IL-22 ( E, Rorc-cre – Fcer1g f/f , n = 7 mice; Rorc-cre + Fcer1g f/f , n = 6 mice) or IL-17A ( G, Rorc-cre – Fcer1g f/f , n = 7 mice; Rorc-cre + Fcer1g f/f , n = 6 mice) -expressing cells in each compartment. H, I Representative flow plots showing the phosphorylation of JAK1, JAK2 and JAK3 in total ILC3s from siLPs of indicated mice on day 5 post the C. albicans infection ( H ). Quantification of MFI ( I, Rorc-cre – Fcer1g f/f , n = 5 mice; Rorc-cre + Fcer1g f/f , n = 4 mice). Data are representative of two ( C – G ) or one ( H , I ) or from two ( A , B ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( B, C, E, G, I ).

    Article Snippet: Mice were injected intraperitoneally with a dose of 1 μg rIL-17A protein (R&D Systems) or 0.8 μg rIL-22 protein (R&D Systems) 6 h before C. albicans infection, followed by a booster dose of the same cytokine at 24 h after infection.

    Techniques: Expressing, Infection, Two Tailed Test

    A Experimental scheme. B Survival curves of C. albicans- infected Rorc-cre + Fcer1g f/f mice treated with IL-17A, IL-22 or vehicle (PBS) ( Rorc-cre – Fcer1g f/f PBS, n = 18 mice; Rorc-cre + Fcer1g f/f PBS, n = 21 mice; Rorc-cre + Fcer1g f/f IL-22, n = 13 mice; Rorc-cre + Fcer1g f/f IL-17A, n = 11 mice). C Quantification of the fungi load in kidneys of mice as in ( A ) on day 5 post the infection ( Rorc-cre – Fcer1g f/f PBS, n = 18 mice; Rorc-cre + Fcer1g f/f PBS, n = 16 mice; Rorc-cre + Fcer1g f/f IL-22, n = 7 mice; Rorc-cre + Fcer1g f/f IL-17A, n = 11 mice). D, E Representative PAS staining images of kidneys of mice as in ( A ) on day 5 post the infection. Boxes: medulla area with mycelia, showing in higher magnification in ( E ). F Quantification of IL-17A in the serum of mice as in Fig. on day 5 post the infection. n = 6 mice per group. Data are representative of three ( D, E ) or one ( F ) or are pooled from four ( B ) or three ( C ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, F ) or log-rank (Mantel-Cox) test ( B ).

    Journal: Nature Communications

    Article Title: Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity

    doi: 10.1038/s41467-024-50266-4

    Figure Lengend Snippet: A Experimental scheme. B Survival curves of C. albicans- infected Rorc-cre + Fcer1g f/f mice treated with IL-17A, IL-22 or vehicle (PBS) ( Rorc-cre – Fcer1g f/f PBS, n = 18 mice; Rorc-cre + Fcer1g f/f PBS, n = 21 mice; Rorc-cre + Fcer1g f/f IL-22, n = 13 mice; Rorc-cre + Fcer1g f/f IL-17A, n = 11 mice). C Quantification of the fungi load in kidneys of mice as in ( A ) on day 5 post the infection ( Rorc-cre – Fcer1g f/f PBS, n = 18 mice; Rorc-cre + Fcer1g f/f PBS, n = 16 mice; Rorc-cre + Fcer1g f/f IL-22, n = 7 mice; Rorc-cre + Fcer1g f/f IL-17A, n = 11 mice). D, E Representative PAS staining images of kidneys of mice as in ( A ) on day 5 post the infection. Boxes: medulla area with mycelia, showing in higher magnification in ( E ). F Quantification of IL-17A in the serum of mice as in Fig. on day 5 post the infection. n = 6 mice per group. Data are representative of three ( D, E ) or one ( F ) or are pooled from four ( B ) or three ( C ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( C, F ) or log-rank (Mantel-Cox) test ( B ).

    Article Snippet: Mice were injected intraperitoneally with a dose of 1 μg rIL-17A protein (R&D Systems) or 0.8 μg rIL-22 protein (R&D Systems) 6 h before C. albicans infection, followed by a booster dose of the same cytokine at 24 h after infection.

    Techniques: Infection, Staining, Two Tailed Test

    A, B Representative flow plots showing the intracellular abundance of IL-17A ( A ) in total, CCR6 + and CCR6 – ILC3s from siLPs of mice with the indicated genotypes on day 5 post C. albicans infection. Quantification of the frequencies of IL-17A-expressing cells in each compartment ( B , WT, n = 7 mice; Ncr1 –/– , n = 5 mice; Fcgr3 –/– , n = 4 mice). C Survival curves of C. albicans- infected Rag1 −/− Rorc-cre − Fcer1g f/f ( n = 8 mice) and Rag1 −/− Rorc-cre + Fcer1g f/f mice ( n = 7 mice). All mice were intravenously infected with C. albicans on day 0 ( Methods ). D Survival curves of C. albicans- infected Rag1 −/− Rorc-cre − Fcer1g f/f and Rag1 −/− Rorc-cre + Fcer1g f/f mice treated with mIgG ( Methods ) ( n = 8 mice per group). E, F Representative flow plots showing the intracellular abundance of IL-17A ( E ) in total, CCR6 + and CCR6 – ILC3s from siLPs of mice in ( D ) on day 5 post the infection. Quantification of the frequencies of IL-17A ( F )-expressing cells in each compartment ( n = 4 mice per group). Data are pooled from three ( A, B ) or representative of three ( C ) or two ( D-F ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( B, F ) or log-rank (Mantel-Cox) test ( C, D ).

    Journal: Nature Communications

    Article Title: Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity

    doi: 10.1038/s41467-024-50266-4

    Figure Lengend Snippet: A, B Representative flow plots showing the intracellular abundance of IL-17A ( A ) in total, CCR6 + and CCR6 – ILC3s from siLPs of mice with the indicated genotypes on day 5 post C. albicans infection. Quantification of the frequencies of IL-17A-expressing cells in each compartment ( B , WT, n = 7 mice; Ncr1 –/– , n = 5 mice; Fcgr3 –/– , n = 4 mice). C Survival curves of C. albicans- infected Rag1 −/− Rorc-cre − Fcer1g f/f ( n = 8 mice) and Rag1 −/− Rorc-cre + Fcer1g f/f mice ( n = 7 mice). All mice were intravenously infected with C. albicans on day 0 ( Methods ). D Survival curves of C. albicans- infected Rag1 −/− Rorc-cre − Fcer1g f/f and Rag1 −/− Rorc-cre + Fcer1g f/f mice treated with mIgG ( Methods ) ( n = 8 mice per group). E, F Representative flow plots showing the intracellular abundance of IL-17A ( E ) in total, CCR6 + and CCR6 – ILC3s from siLPs of mice in ( D ) on day 5 post the infection. Quantification of the frequencies of IL-17A ( F )-expressing cells in each compartment ( n = 4 mice per group). Data are pooled from three ( A, B ) or representative of three ( C ) or two ( D-F ) independent experiments shown as the mean ± SEM. Statistical significance was tested by two-tailed t test ( B, F ) or log-rank (Mantel-Cox) test ( C, D ).

    Article Snippet: Mice were injected intraperitoneally with a dose of 1 μg rIL-17A protein (R&D Systems) or 0.8 μg rIL-22 protein (R&D Systems) 6 h before C. albicans infection, followed by a booster dose of the same cytokine at 24 h after infection.

    Techniques: Infection, Expressing, Two Tailed Test